News
press releaseS
University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity
University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity Independent study confirms revolutionary technology provides accurate results in minutes while
BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home
Monday, August 31, 2020 SPRINGDALE, AR, August 31, 2020 – NOWDiagnostics, Inc. announced today it is working with BARDA, the Biomedical Advanced Research and Development Authority
ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval
ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has received Conformité Européene (CE)
Introducing the ADEXUSDx COVID-19 Test
Introducing the ADEXUSDx COVID-19 Test At NOWDiagnostics, we’re always looking for ways to respond to community needs. Our new, rapid ADEXUSDx COVID-19 serology antibody test
NOWDiagnostics seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test
NOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test The ADEXUSDx® COVID-19 Test is a rapid serology test that detects total antibodies to SARS-CoV-2. It provides